Vinorelbine has been approved in the United States

Studies listed may include approved and non-approved uses, formulations or treatment regimens. Before prescribing any product mentioned in this Register, healthcare Professionals should consult prescribing information approved in their country (view UK and US information for Healthcare Professionals).

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.


vinorelbine studies

Select the study ID number to view the trial summary

Study IDPhaseTitle
VINA2004 II A Phase II, Open-Label, Prospective, Randomized, Controlled, Multicenter Study of Single Agent NAVELBINE (vinorelbine tartrate) Administered Orally or Administered Intravenously for the Treatment of Chemotherapy-Naïve Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) and Chemotherapy- Naïve, Elderly Patients with Inoperable, Stage IIIb NSCLC Who Are Not Candidates for Combination Chemotherapy.
VIN10003 I The Phase I Absolute Bioavailability Study of Oral NAVELBINE (vinorelbine tartrate) in Patients with Solid Tumors.
VIN10004 I An Open-Label Study to Provide Continuing Treatment with NAVELBINE (vinorelbine tartrate) Soft Gelatin Capsules or Injection to Subjects with Solid Tumors.
VINA1001 I A Phase I, Open-Label, Randomized, Crossover Study of Oral and Intravenous NAVELBINE (vinorelbine tartrate) in Subjects with Malignant Solid Tumors and Varying Degrees of Hepatic Function.